 | • レポートコード：QYR9NV02594 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、液体生検用循環バイオマーカーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他に、用途別には、早期がん検診、治療法選択、治療モニタリング、再発モニタリング整形外科にセグメント区分し、液体生検用循環バイオマーカーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・液体生検用循環バイオマーカーの世界市場概要 ・液体生検用循環バイオマーカーの製造コスト構成分析 ・液体生検用循環バイオマーカーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・液体生検用循環バイオマーカーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・液体生検用循環バイオマーカーのセグメント分析（種類別） （循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他） ・液体生検用循環バイオマーカーのセグメント分析（用途別） （早期がん検診、治療法選択、治療モニタリング、再発モニタリング整形外科） ・液体生検用循環バイオマーカーの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Abbott Laboratories、Becton, Dickinson and Company、GE Healthcare、Epigenomics AG、Agilent Technologies、Biocept、Affymetrix、Fluxion Biosciences、） ・液体生検用循環バイオマーカーの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Circulating Biomarker for Liquid Biopsy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Circulating Biomarker for Liquid Biopsy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Circulating Biomarker for Liquid Biopsy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Circulating Biomarker for Liquid Biopsy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Circulating Biomarker for Liquid Biopsy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Circulating Tumor Cells (CTCs)
Circulating Tumor DNA (ctDNA)
Cell-Free DNA (cfDNA)
Extracellular Vesicles (EVs)
Others
Segment by Application
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring Orthopedics
Table of Contents
Executive Summary
1 Industry Overview of Circulating Biomarker for Liquid Biopsy
1.1 Definition of Circulating Biomarker for Liquid Biopsy
1.2 Circulating Biomarker for Liquid Biopsy Segment by Type
1.2.1 Global Circulating Biomarker for Liquid Biopsy Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Circulating Tumor Cells (CTCs)
1.2.3 Circulating Tumor DNA (ctDNA)
1.2.4 Cell-Free DNA (cfDNA)
1.2.5 Extracellular Vesicles (EVs)
1.2.6 Others
1.3 Circulating Biomarker for Liquid Biopsy Segment by Applications
1.3.1 Global Circulating Biomarker for Liquid Biopsy Consumption Comparison by Applications (2014-2025)
1.3.2 Early Cancer Screening
1.3.3 Therapy Selection
1.3.4 Treatment Monitoring
1.3.5 Recurrence Monitoring Orthopedics
1.4 Global Circulating Biomarker for Liquid Biopsy Overall Market
1.4.1 Global Circulating Biomarker for Liquid Biopsy Revenue (2014-2025)
1.4.2 Global Circulating Biomarker for Liquid Biopsy Production (2014-2025)
1.4.3 North America Circulating Biomarker for Liquid Biopsy Status and Prospect (2014-2025)
1.4.4 Europe Circulating Biomarker for Liquid Biopsy Status and Prospect (2014-2025)
1.4.5 China Circulating Biomarker for Liquid Biopsy Status and Prospect (2014-2025)
1.4.6 Japan Circulating Biomarker for Liquid Biopsy Status and Prospect (2014-2025)
1.4.7 Southeast Asia Circulating Biomarker for Liquid Biopsy Status and Prospect (2014-2025)
1.4.8 India Circulating Biomarker for Liquid Biopsy Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Circulating Biomarker for Liquid Biopsy
2.3 Manufacturing Process Analysis of Circulating Biomarker for Liquid Biopsy
2.4 Industry Chain Structure of Circulating Biomarker for Liquid Biopsy
3 Development and Manufacturing Plants Analysis of Circulating Biomarker for Liquid Biopsy
3.1 Capacity and Commercial Production Date
3.2 Global Circulating Biomarker for Liquid Biopsy Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Circulating Biomarker for Liquid Biopsy
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Circulating Biomarker for Liquid Biopsy Production and Capacity Analysis
4.2 Circulating Biomarker for Liquid Biopsy Revenue Analysis
4.3 Circulating Biomarker for Liquid Biopsy Price Analysis
4.4 Market Concentration Degree
5 Circulating Biomarker for Liquid Biopsy Regional Market Analysis
5.1 Circulating Biomarker for Liquid Biopsy Production by Regions
5.1.1 Global Circulating Biomarker for Liquid Biopsy Production by Regions
5.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue by Regions
5.2 Circulating Biomarker for Liquid Biopsy Consumption by Regions
5.3 North America Circulating Biomarker for Liquid Biopsy Market Analysis
5.3.1 North America Circulating Biomarker for Liquid Biopsy Production
5.3.2 North America Circulating Biomarker for Liquid Biopsy Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Circulating Biomarker for Liquid Biopsy Import and Export
5.4 Europe Circulating Biomarker for Liquid Biopsy Market Analysis
5.4.1 Europe Circulating Biomarker for Liquid Biopsy Production
5.4.2 Europe Circulating Biomarker for Liquid Biopsy Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Circulating Biomarker for Liquid Biopsy Import and Export
5.5 China Circulating Biomarker for Liquid Biopsy Market Analysis
5.5.1 China Circulating Biomarker for Liquid Biopsy Production
5.5.2 China Circulating Biomarker for Liquid Biopsy Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Circulating Biomarker for Liquid Biopsy Import and Export
5.6 Japan Circulating Biomarker for Liquid Biopsy Market Analysis
5.6.1 Japan Circulating Biomarker for Liquid Biopsy Production
5.6.2 Japan Circulating Biomarker for Liquid Biopsy Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Circulating Biomarker for Liquid Biopsy Import and Export
5.7 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Analysis
5.7.1 Southeast Asia Circulating Biomarker for Liquid Biopsy Production
5.7.2 Southeast Asia Circulating Biomarker for Liquid Biopsy Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Circulating Biomarker for Liquid Biopsy Import and Export
5.8 India Circulating Biomarker for Liquid Biopsy Market Analysis
5.8.1 India Circulating Biomarker for Liquid Biopsy Production
5.8.2 India Circulating Biomarker for Liquid Biopsy Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Circulating Biomarker for Liquid Biopsy Import and Export
6 Circulating Biomarker for Liquid Biopsy Segment Market Analysis (by Type)
6.1 Global Circulating Biomarker for Liquid Biopsy Production by Type
6.2 Global Circulating Biomarker for Liquid Biopsy Revenue by Type
6.3 Circulating Biomarker for Liquid Biopsy Price by Type
7 Circulating Biomarker for Liquid Biopsy Segment Market Analysis (by Application)
7.1 Global Circulating Biomarker for Liquid Biopsy Consumption by Application
7.2 Global Circulating Biomarker for Liquid Biopsy Consumption Market Share by Application (2014-2019)
8 Circulating Biomarker for Liquid Biopsy Major Manufacturers Analysis
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
8.1.2 Abbott Laboratories Product Introduction, Application and Specification
8.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Becton, Dickinson and Company
8.2.1 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
8.2.2 Becton, Dickinson and Company Product Introduction, Application and Specification
8.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 GE Healthcare
8.3.1 GE Healthcare Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
8.3.2 GE Healthcare Product Introduction, Application and Specification
8.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Epigenomics AG
8.4.1 Epigenomics AG Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
8.4.2 Epigenomics AG Product Introduction, Application and Specification
8.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Agilent Technologies
8.5.1 Agilent Technologies Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
8.5.2 Agilent Technologies Product Introduction, Application and Specification
8.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Biocept
8.6.1 Biocept Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
8.6.2 Biocept Product Introduction, Application and Specification
8.6.3 Biocept Circulating Biomarker for Liquid Biopsy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Affymetrix
8.7.1 Affymetrix Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
8.7.2 Affymetrix Product Introduction, Application and Specification
8.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Fluxion Biosciences
8.8.1 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
8.8.2 Fluxion Biosciences Product Introduction, Application and Specification
8.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Circulating Biomarker for Liquid Biopsy Market
9.1 Global Circulating Biomarker for Liquid Biopsy Market Trend Analysis
9.1.1 Global Circulating Biomarker for Liquid Biopsy Market Size (Volume and Value) Forecast 2019-2025
9.2 Circulating Biomarker for Liquid Biopsy Regional Market Trend
9.2.1 North America Circulating Biomarker for Liquid Biopsy Forecast 2019-2025
9.2.2 Europe Circulating Biomarker for Liquid Biopsy Forecast 2019-2025
9.2.3 China Circulating Biomarker for Liquid Biopsy Forecast 2019-2025
9.2.4 Japan Circulating Biomarker for Liquid Biopsy Forecast 2019-2025
9.2.5 Southeast Asia Circulating Biomarker for Liquid Biopsy Forecast 2019-2025
9.2.6 India Circulating Biomarker for Liquid Biopsy Forecast 2019-2025
9.3 Circulating Biomarker for Liquid Biopsy Market Trend (Product Type)
9.4 Circulating Biomarker for Liquid Biopsy Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Circulating Biomarker for Liquid Biopsy Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Circulating Biomarker for Liquid Biopsy
Table Global Circulating Biomarker for Liquid Biopsy Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Circulating Biomarker for Liquid Biopsy Production Market Share by Types in 2018
Figure Circulating Tumor Cells (CTCs) Product Picture
Figure Circulating Tumor DNA (ctDNA) Product Picture
Figure Cell-Free DNA (cfDNA) Product Picture
Figure Extracellular Vesicles (EVs) Product Picture
Figure Others Product Picture
Table Global Circulating Biomarker for Liquid Biopsy Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Circulating Biomarker for Liquid Biopsy Consumption Market Share by Applications in 2018
Figure Early Cancer Screening
Figure Therapy Selection
Figure Treatment Monitoring
Figure Recurrence Monitoring Orthopedics
Figure Global Circulating Biomarker for Liquid Biopsy Revenue (Million USD) (2014-2025)
Figure Global Circulating Biomarker for Liquid Biopsy Production (K Units) (2014-2025)
Figure North America Circulating Biomarker for Liquid Biopsy Market Size (Million USD) (2014-2025)
Figure Europe Circulating Biomarker for Liquid Biopsy Market Size (Million USD) (2014-2025)
Figure China Circulating Biomarker for Liquid Biopsy Market Size (Million USD) (2014-2025)
Figure Japan Circulating Biomarker for Liquid Biopsy Market Size (Million USD) (2014-2025)
Figure Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size (Million USD) (2014-2025)
Figure India Circulating Biomarker for Liquid Biopsy Market Size (Million USD) (2014-2025)
Table Circulating Biomarker for Liquid Biopsy Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Circulating Biomarker for Liquid Biopsy in 2018
Figure Manufacturing Process Analysis of Circulating Biomarker for Liquid Biopsy
Figure Industry Chain Structure of Circulating Biomarker for Liquid Biopsy
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Circulating Biomarker for Liquid Biopsy Manufacturing Plants Distribution
Table Circulating Biomarker for Liquid Biopsy Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Circulating Biomarker for Liquid Biopsy Capacity (K Units) of Major Manufacturers (2014-2019)
Table Circulating Biomarker for Liquid Biopsy Production (K Units) of Major Manufacturers (2014-2019)
Table Circulating Biomarker for Liquid Biopsy Production Market Share of Major Manufacturers (2014-2019)
Figure Circulating Biomarker for Liquid Biopsy Production Share by Manufacturers in 2018
Table Circulating Biomarker for Liquid Biopsy Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Circulating Biomarker for Liquid Biopsy Revenue Market Share of Major Manufacturers (2014-2019)
Figure Circulating Biomarker for Liquid Biopsy Revenue Share by Manufacturers in 2018
Table Circulating Biomarker for Liquid Biopsy Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Circulating Biomarker for Liquid Biopsy Production by Regions 2014-2019 (K Units)
Table Global Circulating Biomarker for Liquid Biopsy Production Market Share by Regions 2014-2019
Figure Global Circulating Biomarker for Liquid Biopsy Production Market Share by Regions in 2018
Table Global Circulating Biomarker for Liquid Biopsy Revenue by Regions 2014-2019 (Million USD)
Table Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Regions 2014-2019
Figure Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Regions in 2018
Table Global Circulating Biomarker for Liquid Biopsy Consumption by Regions 2014-2019 (K Units)
Table Global Circulating Biomarker for Liquid Biopsy Consumption Market Share by Regions 2014-2019
Figure North America Circulating Biomarker for Liquid Biopsy Production Growth Rate 2014-2019 (K Units)
Figure North America Circulating Biomarker for Liquid Biopsy Revenue Growth Rate 2014-2019 (Million USD)
Table North America Circulating Biomarker for Liquid Biopsy Production, Consumption Import and Export (K Units)
Figure Europe Circulating Biomarker for Liquid Biopsy Production Growth Rate 2014-2019 (K Units)
Figure Europe Circulating Biomarker for Liquid Biopsy Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Circulating Biomarker for Liquid Biopsy Production, Consumption Import and Export (K Units)
Figure China Circulating Biomarker for Liquid Biopsy Production Growth Rate 2014-2019 (K Units)
Figure China Circulating Biomarker for Liquid Biopsy Revenue Growth Rate 2014-2019 (Million USD)
Table China Circulating Biomarker for Liquid Biopsy Production, Consumption Import and Export (K Units)
Figure Japan Circulating Biomarker for Liquid Biopsy Production Growth Rate 2014-2019 (K Units)
Figure Japan Circulating Biomarker for Liquid Biopsy Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Circulating Biomarker for Liquid Biopsy Production, Consumption Import and Export (K Units)
Figure Southeast Asia Circulating Biomarker for Liquid Biopsy Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Circulating Biomarker for Liquid Biopsy Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Circulating Biomarker for Liquid Biopsy Production, Consumption Import and Export (K Units)
Figure India Circulating Biomarker for Liquid Biopsy Production Growth Rate 2014-2019 (K Units)
Figure India Circulating Biomarker for Liquid Biopsy Revenue Growth Rate 2014-2019 (Million USD)
Table India Circulating Biomarker for Liquid Biopsy Production, Consumption Import and Export (K Units)
Figure Global Consumption Circulating Biomarker for Liquid Biopsy Market Share by Application (2014-2019)
Figure Global Value (Consumption) Circulating Biomarker for Liquid Biopsy Market Share by Application (2014-2019)
Table Abbott Laboratories Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
Table Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product Introduction, Application and Specification
Table Abbott Laboratories Circulating Biomarker for Liquid Biopsy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Circulating Biomarker for Liquid Biopsy Production Growth Rate (2014-2019)
Table Abbott Laboratories Circulating Biomarker for Liquid Biopsy Production Market Share (2014-2019)
Figure Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue Market Share (2014-2019)
Table Abbott Laboratories Circulating Biomarker for Liquid Biopsy Main Business and Markets Served
Table Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
Table Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product Introduction, Application and Specification
Table Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Production Growth Rate (2014-2019)
Table Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Production Market Share (2014-2019)
Figure Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue Market Share (2014-2019)
Table Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Main Business and Markets Served
Table GE Healthcare Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
Table GE Healthcare Circulating Biomarker for Liquid Biopsy Product Introduction, Application and Specification
Table GE Healthcare Circulating Biomarker for Liquid Biopsy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare Circulating Biomarker for Liquid Biopsy Production Growth Rate (2014-2019)
Table GE Healthcare Circulating Biomarker for Liquid Biopsy Production Market Share (2014-2019)
Figure GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue Market Share (2014-2019)
Table GE Healthcare Circulating Biomarker for Liquid Biopsy Main Business and Markets Served
Table Epigenomics AG Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
Table Epigenomics AG Circulating Biomarker for Liquid Biopsy Product Introduction, Application and Specification
Table Epigenomics AG Circulating Biomarker for Liquid Biopsy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Epigenomics AG Circulating Biomarker for Liquid Biopsy Production Growth Rate (2014-2019)
Table Epigenomics AG Circulating Biomarker for Liquid Biopsy Production Market Share (2014-2019)
Figure Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue Market Share (2014-2019)
Table Epigenomics AG Circulating Biomarker for Liquid Biopsy Main Business and Markets Served
Table Agilent Technologies Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
Table Agilent Technologies Circulating Biomarker for Liquid Biopsy Product Introduction, Application and Specification
Table Agilent Technologies Circulating Biomarker for Liquid Biopsy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Agilent Technologies Circulating Biomarker for Liquid Biopsy Production Growth Rate (2014-2019)
Table Agilent Technologies Circulating Biomarker for Liquid Biopsy Production Market Share (2014-2019)
Figure Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue Market Share (2014-2019)
Table Agilent Technologies Circulating Biomarker for Liquid Biopsy Main Business and Markets Served
Table Biocept Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
Table Biocept Circulating Biomarker for Liquid Biopsy Product Introduction, Application and Specification
Table Biocept Circulating Biomarker for Liquid Biopsy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocept Circulating Biomarker for Liquid Biopsy Production Growth Rate (2014-2019)
Table Biocept Circulating Biomarker for Liquid Biopsy Production Market Share (2014-2019)
Figure Biocept Circulating Biomarker for Liquid Biopsy Revenue Market Share (2014-2019)
Table Biocept Circulating Biomarker for Liquid Biopsy Main Business and Markets Served
Table Affymetrix Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
Table Affymetrix Circulating Biomarker for Liquid Biopsy Product Introduction, Application and Specification
Table Affymetrix Circulating Biomarker for Liquid Biopsy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Affymetrix Circulating Biomarker for Liquid Biopsy Production Growth Rate (2014-2019)
Table Affymetrix Circulating Biomarker for Liquid Biopsy Production Market Share (2014-2019)
Figure Affymetrix Circulating Biomarker for Liquid Biopsy Revenue Market Share (2014-2019)
Table Affymetrix Circulating Biomarker for Liquid Biopsy Main Business and Markets Served
Table Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Production Sites and Area Served
Table Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product Introduction, Application and Specification
Table Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Production Growth Rate (2014-2019)
Table Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Production Market Share (2014-2019)
Figure Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue Market Share (2014-2019)
Table Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Main Business and Markets Served
Figure Global Circulating Biomarker for Liquid Biopsy Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Circulating Biomarker for Liquid Biopsy Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Circulating Biomarker for Liquid Biopsy Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Circulating Biomarker for Liquid Biopsy Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Circulating Biomarker for Liquid Biopsy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Circulating Biomarker for Liquid Biopsy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Circulating Biomarker for Liquid Biopsy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Circulating Biomarker for Liquid Biopsy Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Circulating Biomarker for Liquid Biopsy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Circulating Biomarker for Liquid Biopsy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Circulating Biomarker for Liquid Biopsy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Circulating Biomarker for Liquid Biopsy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Circulating Biomarker for Liquid Biopsy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Circulating Biomarker for Liquid Biopsy Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Circulating Biomarker for Liquid Biopsy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Circulating Biomarker for Liquid Biopsy by Type (2019-2025)
Table Global Consumption (K Units) of Circulating Biomarker for Liquid Biopsy by Application (2019-2025)
Table Circulating Biomarker for Liquid Biopsy Distributors List
Table Circulating Biomarker for Liquid Biopsy Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
循環バイオマーカーのグローバル市場調査 2019年 The global Circulating Biomarker market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Circulating Biomarker volume and value at global level, regional level and company level. From a global perspective, …- 循環腫瘍細胞の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…
- 肺がん液体生検の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. Scope of the Report: This report studies the Lung Cancer Liquid Biopsy market status and outlook of Global and major regions, from ang…
- 心臓バイオマーカーのグローバル市場調査 2019年 The global Cardiac Biomarker market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cardiac Biomarker volume and value at global level, regional level and company level. From a global perspective, this rep…
- 生検システムのグローバル市場調査 2019年 The global Biopsy System market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Biopsy System volume and value at global level, regional level and company level. From a global perspective, this report repr…